Jean‐Nicolas Munck

Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model

Radan Džodić, Gonzalo Gomez-Abuin, Philippe Rougier et al. · Anti-Cancer Drugs · 2004 · 98 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Cross-resistance to rhodamine 123 in Adriamycin- and daunorubicin-resistant Friend leukemia cell variants.

Haïm Tapiero, Jean‐Nicolas Munck, A Fourcade et al. · PubMed · 1984 · 74 citations

Medicine, Cancer Biology, Pharmacology +17

A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: analysis of predictive parameters of response to treatment

T. Girinsky, Dolores Guillot-Vals, Serge Koscielny et al. · International Journal of Radiation Oncology*Biology*Physics · 2001 · 69 citations

Medicine, Oncology, Radiation Oncology +15

Mantle Cell Lymphomas: Characteristics, Natural History and Prognostic Factors of 45 Cases

Didier Decaudin, Jacques Bosq, Jean‐Nicolas Munck et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1997 · 44 citations

Medicine, Hematology, Oncology +17

Extramedullary Solitary Plasmacytoma of the Head and Neck

Michel-Andre Hotz, Jacques Bosq, G Schwaab et al. · Annals of Otology Rhinology & Laryngology · 1999 · 40 citations

Medicine, Hematology, Oncology +15